Point-of-care testing can bring important diagnostic information directly to patients in their homes. For home health agencies operating in the United States, CLIA-waived POCT devices for home health agencies can support faster clinical decisions without requiring every patient to travel to a laboratory or clinic. But choosing a POCT device is not simply a matter of buying a small analyzer. Home health agencies need to consider CLIA requirements, intended use, specimen collection, analytical performance, quality control, operator training, connectivity, consumable costs, and the practical realities of testing in patients' homes. The FDA's current CLIA database lists numerous waived test systems, including blood glucose monitoring systems, urine testing systems, HbA1c analyzers, infectious disease tests, and other point-of-care technologies. Agencies should verify the current waiver status of the exact test system before purchasing. What Does CLIA-Waived Mean for Home Health Age...
Point-of-care testing can bring important diagnostic information directly to patients in their homes. For home health agencies operating in the United States, CLIA-waived POCT devices for home health agencies can support faster clinical decisions without requiring every patient to travel to a laboratory or clinic. But choosing a POCT device is not simply a matter of buying a small analyzer. Home health agencies need to consider CLIA requirements, intended use, specimen collection, analytical performance, quality control, operator training, connectivity, consumable costs, and the practical realities of testing in patients' homes. The FDA's current CLIA database lists numerous waived test systems, including blood glucose monitoring systems, urine testing systems, HbA1c analyzers, infectious disease tests, and other point-of-care technologies. Agencies should verify the current waiver status of the exact test system before purchasing. What Does CLIA-Waived Mean for Home Health Age...